Improved method for synthesis of low molecular weight protamine-siRNA conjugate
- 주제(키워드) Cell penetrating peptide , siRNA , Conjugate , Conjugation yield , Biomimetic delivery , Crosslinker
- 주제(기타) Pharmacology & Pharmacy
- 설명문(일반) [Yu, Zhili; Pei, Xing; Sun, Lu; He, Huining] Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R China; [Ye, Junxiao] Tsinghua Univ, Coll Pharm, Beijing 100084, Peoples R China; [Liu, Ergang] Tianjin Univ, Collaborat Innovat Ctr Chem Sci & Chem Engn & Tec, Tianjin 300072, Peoples R China; [Wang, Jianxin] Minist Educ, Key Lab Smart Drug Delivery, Shanghai 201201, Peoples R China; [Wang, Jianxin] PLA, Shanghai 201201, Peoples R China; [Wang, Jianxin] Fudan Univ, Minist Educ, Sch Pharm, Dept Pharmaceut, Shanghai 201201, Peoples R China; [Huang, Yongzhuo] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Lee, Seung Jin] Ewha Womans Univ, Dept Pharm, Seoul 120750, South Korea
- 등재 SCOPUS
- 발행기관 INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
- 발행년도 2018
- URI http://www.dcollection.net/handler/ewha/000000151418
- 본문언어 영어
- Published As http://dx.doi.org/10.1016/j.apsb.2017.11.011
초록/요약
RNAi technology has aroused wide public interest due to its high efficiency and specificity to treat multiple types of diseases. However, the effective delivery of siRNA remains a challenge due to its large molecular weight and strong anionic charge. Considering their remarkable functions in vivo and features that are often desired in drug delivery carriers, biomimetic systems for siRNA delivery become an effective and promising strategy. Based on this, covalent attachment of synthetic cell penetrating peptides (CPP) to siRNA has become of great interest. We developed a monomeric covalent conjugate of low molecular weight protamine (LMWP, a well-established CPP) and siRNA via a cytosol-cleavable disulfide linkage using PEG as a crosslinker. Results showed that the conjugates didn't generate coagulation, and exhibited much better RNAi potency and intracellular delivery compared with the conventional charge-complexed CPP/siRNA aggregates. Three different synthetic and purification methods were compared in order to optimize synthesis efficiency and product yield. The methodology using hetero-bifunctional NHS-PEG-OPSS as a crosslinker to synthesize LMWP siRNA simplified the synthesis and purification process and produced the highest yield. These results pave the way towards siRNA biomimetic delivery and future clinical translation. (C) 2018 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
more